Early Reduction of Lesion Volume is Associated with Complete Early Recanalization in Stroke Patients Treated with Intravenous tissue-Plasminogen Activator Therapy

被引：0
|
作者：
Sakamoto, Yuki [1 ]
Iguchi, Yasuyuki [1 ]
Watanabe, Masao [1 ]
Iwanaga, Takeshi [1 ]
Matsumoto, Noriko [1 ]
Shibazaki, Kensaku [1 ]
Kimura, Kazumi [1 ]
机构：
[1] Kawasaki Med Sch, Kurashiki, Okayama, Japan
来源：
STROKE | 2011年 / 42卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：E167 / E167
页数：1
相关论文
共 50 条
  • [31] Uric acid therapy improves the outcomes of stroke patients treated with intravenous tissue plasminogen activator and mechanical thrombectomy
    Chamorro, Angel
    Amaro, Sergio
    Castellanos, Mar
    Gomis, Meritxell
    Urra, Xabier
    Blasco, Jordi
    Arenillas, Juan F.
    Roman, Luis S.
    Munoz, Roberto
    Macho, Juan
    Canovas, David
    Marti-Fabregas, Joan
    Leira, Enrique C.
    Planas, Anna M.
    INTERNATIONAL JOURNAL OF STROKE, 2017, 12 (04) : 377 - 382
  • [32] Influence of pretreatment MRI parameters on clinical outcome, recanalization and infarct size in 49 stroke patients treated by intravenous tissue plasminogen activator
    Derex, L
    Nighoghossian, N
    Hermier, M
    Adeleine, P
    Berthezène, Y
    Philippeau, F
    Honnorat, K
    Froment, JC
    Trouillas, P
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2004, 225 (1-2) : 3 - 9
  • [33] Effects of edaravone on early outcomes in acute ischemic stroke patients treated with recombinant tissue plasminogen activator
    Wada, Tomoki
    Yasunaga, Hideo
    Inokuchi, Ryota
    Horiguchi, Hiromasa
    Fushimi, Kiyohide
    Matsubara, Takehiro
    Nakajima, Susumu
    Yahagi, Naoki
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2014, 345 (1-2) : 106 - 111
  • [34] Early Endovascular Treatment in Intravenous Tissue Plasminogen Activator-Ineligible Patients
    Rebello, Leticia C.
    Haussen, Diogo C.
    Grossberg, Jonathan A.
    Belagaje, Samir
    Lima, Andrey
    Anderson, Aaron
    Frankel, Michael R.
    Nogueira, Raul G.
    STROKE, 2016, 47 (04) : 1131 - 1134
  • [35] Addressing the Role of Intravenous Tissue-Plasminogen Activator in Patients with Large Vessel Occlusions
    Zussman, Benjamin
    Weiner, Gregory
    Ducruet, Andrew
    NEUROSURGERY, 2018, 82 (05) : E109 - E110
  • [36] More Time Is Taken to Administer Intravenous Tissue-Plasminogen Activator (tPA) in Ischemic Stroke Patients with Earlier Presentations
    Rossi, Kyle C.
    Liang, John W.
    Tuhrim, Stanley
    Dhamoon, Mandip S.
    ANNALS OF NEUROLOGY, 2016, 80 : S73 - S73
  • [37] Early recanalization after intravenous administration of recombinant tissue plasminogen activator as assessed by pre- and post-thrombolytic angiography in acute ischemic stroke patients
    Lee, Kyung-Yul
    Han, Sang Won
    Kim, Seo Hyun
    Nam, Hyo Seok
    Ahn, Sung Whan
    Kim, Dong Joon
    Seo, Sang Hyun
    Kim, Dong Ik
    Heo, Ji Hoe
    STROKE, 2007, 38 (01) : 192 - 193
  • [38] Recanalization Rate and Clinical Outcomes of Intravenous Tissue Plasminogen Activator Administration for Large Vessel Occlusion Stroke Patients
    Lee, Min-Hyung
    Im, Sang-Hyuk
    Jo, Kwang Wook
    Yoo, Do-Sung
    JOURNAL OF KOREAN NEUROSURGICAL SOCIETY, 2023, 66 (02) : 144 - 154
  • [39] Intravenous Tissue-Plasminogen Activator Treatment in Acute Ischemic Stroke Does Not Prevent Infarct Growth in Patients with Anterior Circulation Stroke
    Truong, Vincent
    Spray, Rori
    Vaishnav, Anand
    Ziegler, Craig
    Remmel, Kerri
    Abou-Chebl, Alex
    NEUROLOGY, 2011, 76 (09) : A309 - A309
  • [40] Prediction of Early Arterial Recanalization and Tissue Fate in the Selection of Patients With the Greatest Potential to Benefit From Intravenous Tissue-Type Plasminogen Activator
    Leiva-Salinas, Carlos
    Patrie, James T.
    Xin, Wenjun
    Michel, Patrik
    Jovin, Tudor
    Wintermark, Max
    STROKE, 2016, 47 (02) : 397 - 403
12345